Linda Neuman

Linda Neuman is an accomplished medical professional with extensive experience in clinical development and leadership roles within the biotechnology and pharmaceutical industries. Currently serving as Vice President of Clinical Development and Asset Leader at Nurix Therapeutics, Linda has held key positions including Chief Medical Officer and Senior Vice President Clinical Development at Aeglea BioTherapeutics, as well as Vice President at Catalyst Biosciences and Adverum Biotechnologies, Inc. An educational background includes a Doctor of Medicine degree from Southern Illinois University School of Medicine and an MBA from Indiana Wesleyan University.